Save the dates! PepGen will be participating in two upcoming investor conferences this month: Leerink Partners Global Healthcare Conference 2025 and Stifel Financial Corp. 2025 Virtual CNS Forum. More details: investors.pepgen.com/news-releases/…

PepGen will present at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference in Dallas, TX. Oral presentations will highlight data from the ongoing CONNECT1-EDO51 trial in #DMD and the recently announced initial results from the FREEDOM-EDODM1 trial in #DM1. investors.pepgen.com/news-releases/…

This afternoon, PepGen will be participating in a fireside chat at the Leerink Partners Global Healthcare Conference 2025. Watch the webcast here: investors.pepgen.com/news-events/ev…

The FREEDOM-DM1 study is researching a possible new medication for people with myotonic dystrophy type 1 (DM1). If you or a loved one is living with 3DM1, visit the FREEDOM-DM1 study at freedom-dm1.com to learn more about the clinical trial.

“When we have community members on site… it invigorates us to keep overcoming obstacles and roadblocks and push forward toward our why.” - Leah Larsen, Manager of Lab Operations on the importance of community events at our Boston office #DMD #DM1 #Advocacy

Today, PepGen will be participating in a fireside chat at the Stifel 2025 Virtual CNS Forum. Watch the webcast here: investors.pepgen.com/news-events/ev…

We are excited to welcome Lisa Wyman and Mitchell H Finer, PhD, to our Board of Directors. Both are industry veterans who bring decades of executive experience in the life sciences to PepGen. Read more here: investors.pepgen.com/news-releases/…

Mark your calendar! Next week, PepGen will be presenting at the 24th Annual Needham Virtual Healthcare Conference. More details: investors.pepgen.com/news-releases/…

There are many different people who come together to run a clinical trial. In lesson 6, Professor PepGen will teach you exactly which groups are involved in running clinical trials. #ClinicalTrialAwareness #Education #DMD #DM1

This afternoon, PepGen will be presenting at the 24th Annual Needham Virtual Healthcare Conference. Join us for the webcast here: investors.pepgen.com/news-events/ev…

“Person-centered care is where the person is at the center of everything we do… When we can slow down and create opportunities to hear that lived experience, it brings us back to the anchor.” Kasha Mitton, DMD Mom, Nurse, and Advocate #Advocacy #PatientFocusedDrugDevelopment

Have you been diagnosed with myotonic dystrophy type 1 (DM1)? Consider joining the FREEDOM-DM1 study, a phase 1 clinical research study investigating a new potential medication for DM1. Visit the FREEDOM-DM1 study today at freedom-dm1.com

This weekend, we will be attending Myotonic Dystrophy Foundation's Annual Conference in Indianapolis, Indiana! We will give #DM1 program updates in two presentations. We look forward to seeing you there!

Last weekend, we attended Myotonic Dystrophy Foundation's Annual Conference, and left feeling inspired by the incredible members of the #DM1 community.

Today, we shared our financial results for the first quarter and recent corporate highlights. Learn more: investors.pepgen.com/news-releases/…

Today we celebrate #ClinicalTrialAwarenessDay. We are grateful to all who make our clinical trials possible. Check out our trials here: pepgen.com/pipeline/#clin…

We’re thrilled to welcome Kasra Kasraian, PhD, as our Chief Technology Officer. He brings 25+ years of experience in product and process development, CMC strategy, & technical operations. Read more: investors.pepgen.com/news-releases/…

This weekend, we’re heading to San Antonio, Texas for CureDuchenne’s 2025 FUTURES National Conference. Every year, we look forward to connecting with the #DMD community at FUTURES. We hope to see you at our booth and our presentation. #2025FUTURES #CureDuchenne

Have you been diagnosed with myotonic dystrophy type 1 (DM1)? Consider joining the FREEDOM-DM1 study, a phase 1 clinical research study investigating a new potential medication for DM1. Visit the FREEDOM-DM1 study today at freedom-dm1.com

Last week, our team kicked off summer with a Boston Duck Boat tour—an afternoon of fun, fresh air, and team bonding. This outing was the perfect way to recharge and connect outside the office.